Home › Research › Tau biomarkers
[News on blood biomarker-based early diagnosis of the preliminary stages of Alzheimer's dementia]
Hansen N, Wiltfang J.. Fortschritte der Neurologie-Psychiatrie, 2025-11-06
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
The early diagnosis of Alzheimer's disease (ADD) has gained new significance through the further discovery of blood biomarkers. Blood biomarkers are less expensive, can be measured fully automatically with high throughput, are less invasive and provide faster information on specific dementia biomarkers than current methods used in routine clinical practice such as amyloid positron emission tomography (PET) or CSF examination of underlying pathological changes in Alzheimer's disease (AD) in patients with cognitive impairment. The aim of this review is to provide a presentation of the added value of blood-based biomarkers for the early diagnosis of ADD.
What this study adds
Evidence grade: Low
This is a narrative review. This review describes the added value of blood-based biomarkers for early diagnosis of Alzheimer's dementia, noting they are less expensive, less invasive and faster than amyloid PET or CSF examination. It concerns diagnosis only and reports nothing about treating, curing or preventing the disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Hansen, N., & Wiltfang, J. (2025). [News on blood biomarker-based early diagnosis of the preliminary stages of Alzheimer's dementia]. Fortschritte der Neurologie-Psychiatrie. https://doi.org/10.1055/a-2698-5992
Vancouver
Hansen N, Wiltfang J. [News on blood biomarker-based early diagnosis of the preliminary stages of Alzheimer's dementia]. Fortschritte der Neurologie-Psychiatrie. 2025. doi:10.1055/a-2698-5992. PMID: 41197657.
BibTeX
@article{hansen2025-41197657,
author = {Hansen, N. and Wiltfang, J.},
title = {{[News on blood biomarker-based early diagnosis of the preliminary stages of Alzheimer's dementia]}},
journal = {Fortschritte der Neurologie-Psychiatrie},
year = {2025},
doi = {10.1055/a-2698-5992},
pmid = {41197657},
url = {https://doi.org/10.1055/a-2698-5992}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Blood biomarkers are less expensive, can be measured fully automatically with high throughput, are less invasive and provide faster information on specific dementia biomarkers than current methods used in routine clinical practice such as amyloid positron emission tomography (PET) or CSF examination of underlying pathological changes in Alzheimer's disease (AD) in patients with cognitive impairment.
- The aim of this review is to provide a presentation of the added value of blood-based biomarkers for the early diagnosis of ADD.
- Individual blood biomarkers are presented regarding their diagnostic reliability and predictive value for the diagnosis of AD in precursors of ADD ranging from subjective cognitive impairment (SCD) to mild cognitive impairment (MCI).
- In addition, the revised criteria for the diagnosis and staging of AD are discussed.
Why it matters
This review describes the added value of blood-based biomarkers for early diagnosis of Alzheimer's dementia, noting they are less expensive, less invasive and faster than amyloid PET or CSF examination. It concerns diagnosis only and reports nothing about treating, curing or preventing the disease.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Evidence strengthLow
How this study scored 30/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Fortschritte der Neurologie-Psychiatrie) |
| Journal's citation record | 0 / 4 | Fortschritte der Neurologie · Psychiatrie: journal h-index 48 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Jens Wiltfang: h-index 95 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | German Center for Neurodegenerative Diseases: institution h-index 524 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41197657) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 30 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1055/a-2698-5992
- PubMed: 41197657
- Original source →
- Free full text: GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.